Alwin Kraemer

1.2k total citations
22 papers, 899 citations indexed

About

Alwin Kraemer is a scholar working on Oncology, Hematology and Cell Biology. According to data from OpenAlex, Alwin Kraemer has authored 22 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Hematology and 7 papers in Cell Biology. Recurrent topics in Alwin Kraemer's work include Multiple Myeloma Research and Treatments (8 papers), Microtubule and mitosis dynamics (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Alwin Kraemer is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Microtubule and mitosis dynamics (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Alwin Kraemer collaborates with scholars based in Germany, United States and France. Alwin Kraemer's co-authors include Anthony D. Ho, Kai Neben, Hartmut Goldschmidt, Thomas Moehler, George Yerganian, Peter Duesberg, Andreas Willer, Rüediger Hehlmann, Axel Benner and Gerlinde Egerer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Oncogene.

In The Last Decade

Alwin Kraemer

21 papers receiving 875 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alwin Kraemer Germany 12 485 290 241 174 170 22 899
Noël Philippe France 13 647 1.3× 261 0.9× 213 0.9× 115 0.7× 125 0.7× 17 1.3k
Lisa J. McReynolds United States 19 643 1.3× 293 1.0× 211 0.9× 131 0.8× 107 0.6× 51 1.4k
Martina Minnich Austria 13 505 1.0× 210 0.7× 166 0.7× 131 0.8× 99 0.6× 15 1.7k
Kelly Barnes United States 7 1.1k 2.3× 270 0.9× 325 1.3× 74 0.4× 198 1.2× 9 1.7k
Evelyne Lauret France 19 610 1.3× 222 0.8× 240 1.0× 77 0.4× 108 0.6× 49 1.2k
D Mathieu-Mahul France 20 742 1.5× 241 0.8× 369 1.5× 139 0.8× 99 0.6× 47 1.5k
Taiju Utsugisawa Japan 15 772 1.6× 285 1.0× 188 0.8× 64 0.4× 106 0.6× 39 1.0k
S A Cannistra United States 15 405 0.8× 324 1.1× 141 0.6× 121 0.7× 98 0.6× 24 1.1k
Yasuhiko Kamikubo Japan 16 656 1.4× 156 0.5× 448 1.9× 138 0.8× 118 0.7× 43 1.0k
Nuria Mencia-Trinchant United States 14 579 1.2× 222 0.8× 468 1.9× 163 0.9× 288 1.7× 27 1.3k

Countries citing papers authored by Alwin Kraemer

Since Specialization
Citations

This map shows the geographic impact of Alwin Kraemer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alwin Kraemer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alwin Kraemer more than expected).

Fields of papers citing papers by Alwin Kraemer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alwin Kraemer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alwin Kraemer. The network helps show where Alwin Kraemer may publish in the future.

Co-authorship network of co-authors of Alwin Kraemer

This figure shows the co-authorship network connecting the top 25 collaborators of Alwin Kraemer. A scholar is included among the top collaborators of Alwin Kraemer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alwin Kraemer. Alwin Kraemer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kraemer, Alwin, et al.. (2012). Clinical signs, therapy and zoonotic risk of pet guinea pigs with dermatophytosis. Mycoses. 56(2). 168–172. 24 indexed citations
3.
Kraemer, Alwin, et al.. (2011). Dermatophytes in pet Guinea pigs and rabbits. Veterinary Microbiology. 157(1-2). 208–213. 51 indexed citations
4.
Breitkreutz, Iris, Thomas Ostenfeld Larsen, Mads H. Clausen, et al.. (2009). B570 Centrosomal Clustering: A Novel Therapeutic Target for Multiple Myeloma. Clinical Lymphoma & Myeloma. 9. S153–S153. 1 indexed citations
5.
Tagscherer, Katrin E., Anne Fassl, Benito Campos, et al.. (2008). Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins. Oncogene. 27(52). 6646–6656. 179 indexed citations
6.
Witzens‐Harig, Mathias, Axel Benner, Manfred Hensel, et al.. (2008). Quality of life during maintenance therapy with the anti-CD20 antibody rituximab in patients with B cell non-Hodgkin’s lymphoma: results of a prospective randomized controlled trial. Annals of Hematology. 88(1). 51–57. 24 indexed citations
7.
Fabarius, Alice, Michelle Giehl, Alwin Kraemer, et al.. (2006). Centrosome Aberrations, Disturbed Mitotic Spindle Formation and G1 Arrest in Normal and Leukemic Cells Treated with the SRC/ABL Inhibitor Dasatinib.. Blood. 108(11). 2167–2167. 4 indexed citations
8.
Bochtler, Tilmann, et al.. (2005). ATM and ATR Are Not Required for DNA Damage-Dependent Accumulation of Chk1 at the Centrosome.. Blood. 106(11). 4288–4288. 1 indexed citations
9.
Witzens‐Harig, Mathias, Manfred Hensel, Kai Neben, et al.. (2005). Rituximab Maintenenance Therapy in CD20+ B-Cell Non-Hodgkin-Lymphoma - First Interim Results of a Prospective Randomised Phase II Study.. Blood. 106(11). 2454–2454. 3 indexed citations
10.
Leo, Eugen, Ingo G.H. Schmidt‐Wolf, M. Kerowgan, et al.. (2004). Significant thrombocytopenia associated with the addition of rituximab to a combination of fludarabine and cyclophosphamide in the treatment of relapsed follicular lymphoma. European Journal Of Haematology. 73(4). 251–257. 10 indexed citations
11.
Moehrle, Matthias, Alwin Kraemer, Wilfried Schippert, et al.. (2004). Clinical risk factors and prognostic significance of local recurrence in cutaneous melanoma. British Journal of Dermatology. 151(2). 397–406. 37 indexed citations
12.
Seggewiss, Ruth, Anthony D. Ho, & Alwin Kraemer. (2004). Remarkable response to rituximab in a patient with atypical CD20 ++ mantle cell lymphoma of the bone marrow leading to severe pancytopenia. Annals of Hematology. 83(5). 316–318. 3 indexed citations
13.
Kornacker, Martin, et al.. (2002). Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin's lymphoma: report of two cases. Annals of Hematology. 81(2). 103–105. 45 indexed citations
14.
Neben, Kai, Joannis Mytilineos, Thomas Moehler, et al.. (2002). Polymorphisms of the tumor necrosis factor-α gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma. Blood. 100(6). 2263–2265. 68 indexed citations
15.
Neben, Kai, Thomas Moehler, Axel Benner, et al.. (2002). Dose-dependent effect of thalidomide on overall survival in relapsed multiple myeloma.. PubMed. 8(11). 3377–82. 83 indexed citations
16.
Neben, Kai, Thomas Moehler, Alwin Kraemer, et al.. (2001). Response to thalidomide in progressive multiple myeloma is not mediated by inhibition of angiogenic cytokine secretion. British Journal of Haematology. 115(3). 605–608. 55 indexed citations
17.
Neben, Kai, Thomas Moehler, Gerlinde Egerer, et al.. (2001). High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma.. PubMed. 7(9). 2675–81. 56 indexed citations
18.
Duesberg, Peter, Ruhong Li, David Rasnick, et al.. (2000). Aneuploidy Precedes and Segregates with Chemical Carcinogenesis. Cancer Genetics and Cytogenetics. 119(2). 83–93. 99 indexed citations
19.
Neben, Kai, Thomas Moehler, Gerlinde Egerer, et al.. (2000). High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma. 96. 3 indexed citations
20.
Li, Ruhong, George Yerganian, Peter Duesberg, et al.. (1997). Aneuploidy correlated 100% with chemical transformation of Chinese hamster cells. Proceedings of the National Academy of Sciences. 94(26). 14506–14511. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noël Philippe Breakdown of academic impact, for papers by Lisa J. McReynolds Breakdown of academic impact, for papers by Martina Minnich Breakdown of academic impact, for papers by Kelly Barnes Breakdown of academic impact, for papers by Evelyne Lauret Breakdown of academic impact, for papers by D Mathieu-Mahul Breakdown of academic impact, for papers by Taiju Utsugisawa Breakdown of academic impact, for papers by S A Cannistra Breakdown of academic impact, for papers by Yasuhiko Kamikubo Breakdown of academic impact, for papers by Nuria Mencia-Trinchant
Rankless by CCL
2026